Two Sigma Investments’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Sell |
125,298
-29,487
| -19% | -$133K | ﹤0.01% | 2488 |
|
|
2025
Q1 | $686K | Buy |
154,785
+66,448
| +75% | +$294K | ﹤0.01% | 2315 |
|
|
2024
Q4 | $692K | Buy |
88,337
+21,196
| +32% | +$166K | ﹤0.01% | 2316 |
|
|
2024
Q3 | $883K | Buy |
67,141
+5,825
| +9% | +$76.6K | ﹤0.01% | 2140 |
|
|
2024
Q2 | $741K | Sell |
61,316
-42,986
| -41% | -$519K | ﹤0.01% | 2086 |
|
|
2024
Q1 | $1.7M | Buy |
104,302
+42,463
| +69% | +$690K | ﹤0.01% | 1542 |
|
|
2023
Q4 | $422K | Sell |
61,839
-11,192
| -15% | -$76.3K | ﹤0.01% | 2465 |
|
|
2023
Q3 | $398K | Sell |
73,031
-91,743
| -56% | -$500K | ﹤0.01% | 2303 |
|
|
2023
Q2 | $1.12M | Buy |
164,774
+9,147
| +6% | +$62.1K | ﹤0.01% | 1813 |
|
|
2023
Q1 | $780K | Sell |
155,627
-53,839
| -26% | -$270K | ﹤0.01% | 1928 |
|
|
2022
Q4 | $1.02M | Buy |
+209,466
| New | +$1.02M | ﹤0.01% | 1632 |
|
|
2022
Q1 | – | Sell |
-38,792
| Closed | -$629K | – | 3192 |
|
|
2021
Q4 | $629K | Buy |
+38,792
| New | +$629K | ﹤0.01% | 1883 |
|
|
2021
Q3 | – | Sell |
-46,228
| Closed | -$1.56M | – | 3060 |
|
|
2021
Q2 | $1.56M | Sell |
46,228
-227,989
| -83% | -$7.71M | ﹤0.01% | 1474 |
|
|
2021
Q1 | $8.29M | Buy |
274,217
+194,975
| +246% | +$5.9M | 0.02% | 645 |
|
|
2020
Q4 | $3.92M | Sell |
79,242
-13,257
| -14% | -$656K | 0.01% | 820 |
|
|
2020
Q3 | $3.55M | Sell |
92,499
-55,176
| -37% | -$2.12M | 0.01% | 717 |
|
|
2020
Q2 | $6.38M | Buy |
147,675
+26,895
| +22% | +$1.16M | 0.03% | 458 |
|
|
2020
Q1 | $3.15M | Sell |
120,780
-51,557
| -30% | -$1.35M | 0.03% | 539 |
|
|
2019
Q4 | $5.39M | Buy |
172,337
+160,562
| +1,364% | +$5.02M | 0.02% | 713 |
|
|
2019
Q3 | $307K | Buy |
+11,775
| New | +$307K | ﹤0.01% | 1635 |
|